Literature DB >> 7747817

Derivation of phenobarbital-responsive immortal rat hepatocytes.

C Chiao1, Y Zhang, D G Kaufman, W K Kaufmann.   

Abstract

Two lines of rat hepatocytes, designated 6/15 and 6/27, were obtained from carcinogen-treated livers by cultivation in medium containing the liver tumor promoter, phenobarbital (PB). Both lines appeared to be PB-responsive and to have an unlimited in vitro proliferative lifespan, i.e., immortality. The ability of pure 6/27 hepatocytes to form colonies from single cells was strictly dependent upon PB; it was reduced by 97 to 99% in the absence of PB. These hepatocytes were not tumorigenic. For 6/27 hepatocytes in early passages where cultures contained fibroblast contaminants and later when they were a pure culture, PB was able to enhance colony growth from single cells and facilitated population expansion by sustaining DNA synthesis and by inhibiting cell lysis. The 6/15 line displayed PB-dependent colony formation and was not tumorigenic at early passages. At later passages 6/15 hepatocytes were less dependent on PB for colony formation, and they formed hepatocellular carcinoma when transplanted into livers of syngeneic rats. The demonstration that PB sustained the proliferation and viability of hepatocytes with enhanced growth capacity and indefinite proliferative lifespan suggests that PB may be necessary for progression of these chemically initiated hepatocytes to immortal and tumorigenic lines in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747817      PMCID: PMC1869282     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  The two-stage mechanism controlling cellular senescence and immortalization.

Authors:  W E Wright; J W Shay
Journal:  Exp Gerontol       Date:  1992 Jul-Aug       Impact factor: 4.032

2.  Transformation of cultured fetal rat liver cells by MDAB and phenobarbital. Morphological, biochemical and immunocytochemical characterization of cell lines.

Authors:  G Yeoh; I Porter; M Arcus; A Douglas
Journal:  Carcinogenesis       Date:  1989-06       Impact factor: 4.944

Review 3.  Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.

Authors:  C W Boone; G J Kelloff; V E Steele
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

4.  Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-beta 1 expression.

Authors:  R L Jirtle; S A Meyer
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

5.  Squamous metaplasia of normal and carcinoma in situ of HPV 16-immortalized human endocervical cells.

Authors:  Q Sun; K Tsutsumi; M B Kelleher; A Pater; M M Pater
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

6.  Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line.

Authors:  A M Sizeland; A W Burgess
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

Review 7.  Defining the molecular mechanisms of human cell immortalization.

Authors:  J W Shay; W E Wright; H Werbin
Journal:  Biochim Biophys Acta       Date:  1991-04-16

8.  ras transformation of simian virus 40-immortalized rat hepatocytes: an in vitro model of hepatocarcinogenesis.

Authors:  X J Fang; M Flowers; A Keating; R Cameron; M Sherman
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

9.  DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.

Authors:  R Schulte-Hermann; I Timmermann-Trosiener; G Barthel; W Bursch
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

10.  Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.

Authors:  Y H Xu; H A Campbell; G L Sattler; S Hendrich; R Maronpot; K Sato; H C Pitot
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.